Home/Filings/4/0001179110-09-003092
4//SEC Filing

Druzgala Pascal 4

Accession 0001179110-09-003092

CIK 0001410064other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 9:08 PM ET

Size

5.7 KB

Accession

0001179110-09-003092

Insider Transaction Report

Form 4
Period: 2009-02-18
Druzgala Pascal
Sr. V.P. & Chief Scien.Off.
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-02-18+60,00060,000 total
    Exercise: $2.70Exp: 2019-02-17Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on February 18, 2010 and one forty-eighth (1/48th) of the shares shall vest monthly thereafter.

Issuer

ARYx Therapeutics, Inc.

CIK 0001410064

Entity typeother

Related Parties

1
  • filerCIK 0001416178

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:08 PM ET
Size
5.7 KB